Monocyte-Macrophages and T Cells in Atherosclerosis

Immunity

Volumn 47, Issue 4, 2017, Pages 621-634

  Tabas, Ira ^a   Lichtman, Andrew H ^b  

^a NewYork Presbyterian Hospital   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

adaptive immunity; effector T cell; inflammation; Innate and adaptive inflammatory responses drive the progression of atherosclerosis; innate immunity; macrophage; monocyte; regulatory T cell; T cell

Indexed keywords

ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; DISEASE EXACERBATION; EFFECTOR CELL; ENERGY METABOLISM; HUMAN; IMMUNOPATHOGENESIS; INFLAMMATION; INFLAMMATORY CELL; LYMPHOCYTE COUNT; LYMPHOCYTE FUNCTION; MACROPHAGE FUNCTION; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE; ADAPTIVE IMMUNITY; ANIMAL; BIOLOGICAL MODEL; IMMUNOLOGY; INNATE IMMUNITY; MACROPHAGE;

LIPOPROTEIN;

ADAPTIVE IMMUNITY; ANIMALS; ATHEROSCLEROSIS; HUMANS; IMMUNITY, INNATE; LIPOPROTEINS; MACROPHAGES; MODELS, IMMUNOLOGICAL; MONOCYTES; T-LYMPHOCYTES;

EID: 85032826385     PISSN: 10747613     EISSN: 10974180     Source Type: Journal    
DOI: 10.1016/j.immuni.2017.09.008     Document Type: Review

References (151)

1. Ait-Oufella, H., Pouresmail, V., Simon, T., Blanc-Brude, O., Kinugawa, K., Merval, R., Offenstadt, G., Lesèche, G., Cohen, P.L., Tedgui, A., Mallat, Z., Defective mer receptor tyrosine kinase signaling in bone marrow cells promotes apoptotic cell accumulation and accelerates atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 28 (2008), 1429–1431.
2. American Heart Association; American Stroke Association (2017). Cardiovascular Disease: A Costly Burden for America—Projections through 2035. https://www.heart.org/idc/groups/heart-public/@wcm/@adv/documents/downloadable/ucm_491543.pdf.
3. Amit, I., Winter, D.R., Jung, S., The role of the local environment and epigenetics in shaping macrophage identity and their effect on tissue homeostasis. Nat. Immunol. 17 (2016), 18–25.
4. Angelin, A., Gil-de-Gómez, L., Dahiya, S., Jiao, J., Guo, L., Levine, M.H., Wang, Z., Quinn, W.J. 3rd, Kopinski, P.K., Wang, L., et al. Foxp3 reprograms T cell metabolism to function in low-glucose, high-lactate environments. Cell Metab. 25 (2017), 1282–1293.e7.
5. Armstrong, A.J., Gebre, A.K., Parks, J.S., Hedrick, C.C., ATP-binding cassette transporter G1 negatively regulates thymocyte and peripheral lymphocyte proliferation. J. Immunol. 184 (2010), 173–183.
6. Aryal, B., Rotllan, N., Fernández-Hernando, C., Noncoding RNAs and atherosclerosis. Curr. Atheroscler. Rep., 16, 2014, 407.
7. Behn, A., Ur, E., The obesity epidemic and its cardiovascular consequences. Curr. Opin. Cardiol. 21 (2006), 353–360.
8. Bekkering, S., Quintin, J., Joosten, L.A., van der Meer, J.W., Netea, M.G., Riksen, N.P., Oxidized low-density lipoprotein induces long-term proinflammatory cytokine production and foam cell formation via epigenetic reprogramming of monocytes. Arterioscler. Thromb. Vasc. Biol. 34 (2014), 1731–1738.
9. Bekkering, S., van den Munckhof, I., Nielen, T., Lamfers, E., Dinarello, C., Rutten, J., de Graaf, J., Joosten, L.A., Netea, M.G., Gomes, M.E., Riksen, N.P., Innate immune cell activation and epigenetic remodeling in symptomatic and asymptomatic atherosclerosis in humans in vivo. Atherosclerosis 254 (2016), 228–236.
10. Bengsch, B., Johnson, A.L., Kurachi, M., Odorizzi, P.M., Pauken, K.E., Attanasio, J., Stelekati, E., McLane, L.M., Paley, M.A., Delgoffe, G.M., Wherry, E.J., Bioenergetic insufficiencies due to metabolic alterations regulated by the inhibitory receptor PD-1 are an early driver of CD8(+) T Cell exhaustion. Immunity 45 (2016), 358–373.
11. Bennett, M.R., Sinha, S., Owens, G.K., Vascular Smooth Muscle Cells in Atherosclerosis. Circ. Res. 118 (2016), 692–702.
12. Borén, J., Williams, K.J., The central role of arterial retention of cholesterol-rich apolipoprotein-B-containing lipoproteins in the pathogenesis of atherosclerosis: a triumph of simplicity. Curr. Opin. Lipidol. 27 (2016), 473–483.
13. Bornfeldt, K.E., Tabas, I., Insulin resistance, hyperglycemia, and atherosclerosis. Cell Metab. 14 (2011), 575–585.
14. Brown, J.D., Lin, C.Y., Duan, Q., Griffin, G., Federation, A., Paranal, R.M., Bair, S., Newton, G., Lichtman, A., Kung, A., et al. NF-κB directs dynamic super enhancer formation in inflammation and atherogenesis. Mol. Cell 56 (2014), 219–231.
15. Burkett, P.R., Meyer zu Horste, G., Kuchroo, V.K., Pouring fuel on the fire: Th17 cells, the environment, and autoimmunity. J. Clin. Invest. 125 (2015), 2211–2219.
16. + Th1/Tregs. Circ. Res. 119 (2016), 1190–1203.
17. Cai, B., Thorp, E.B., Doran, A.C., Subramanian, M., Sansbury, B.E., Lin, C.S., Spite, M., Fredman, G., Tabas, I., MerTK cleavage limits proresolving mediator biosynthesis and exacerbates tissue inflammation. Proc. Natl. Acad. Sci. USA 113 (2016), 6526–6531.
18. Cai, B., Thorp, E.B., Doran, A.C., Sansbury, B.E., Daemen, M.J., Dorweiler, B., Spite, M., Fredman, G., Tabas, I., MerTK receptor cleavage promotes plaque necrosis and defective resolution in atherosclerosis. J. Clin. Invest. 127 (2017), 564–568.
19. Camenisch, T.D., Koller, B.H., Earp, H.S., Matsushima, G.K., A novel receptor tyrosine kinase, Mer, inhibits TNF-alpha production and lipopolysaccharide-induced endotoxic shock. J. Immunol. 162 (1999), 3498–3503.
20. Chaudhari, S.M., Sluimer, J.C., Koch, M., Theelen, T.L., Manthey, H.D., Busch, M., Caballero-Franco, C., Vogel, F., Cochain, C., Pelisek, J., et al. Deficiency of HIF1α in antigen-presenting cells aggravates atherosclerosis and type 1 T-helper cell responses in mice. Arterioscler. Thromb. Vasc. Biol. 35 (2015), 2316–2325.
21. Chen, H.H., Keyhanian, K., Zhou, X., Vilmundarson, R.O., Almontashiri, N.A., Cruz, S.A., Pandey, N.R., Lerma Yap, N., Ho, T., Stewart, C.A., et al. IRF2BP2 reduces macrophage inflammation and susceptibility to atherosclerosis. Circ. Res. 117 (2015), 671–683.
22. Cheng, H.Y., Gaddis, D.E., Wu, R., McSkimming, C., Haynes, L.D., Taylor, A.M., McNamara, C.A., Sorci-Thomas, M., Hedrick, C.C., Loss of ABCG1 influences regulatory T cell differentiation and atherosclerosis. J. Clin. Invest. 126 (2016), 3236–3246.
23. Childs, B.G., Baker, D.J., Wijshake, T., Conover, C.A., Campisi, J., van Deursen, J.M., Senescent intimal foam cells are deleterious at all stages of atherosclerosis. Science 354 (2016), 472–477.
24. Chiurchiù V., Leuti, A., Dalli, J., Jacobsson, A., Battistini, L., Maccarrone, M., Serhan, C.N., Proresolving lipid mediators resolvin D1, resolvin D2, and maresin 1 are critical in modulating T cell responses. Sci. Transl. Med., 8, 2016, 353ra111.
25. Deloukas, P., Kanoni, S., Willenborg, C., Farrall, M., Assimes, T.L., Thompson, J.R., Ingelsson, E., Saleheen, D., Erdmann, J., Goldstein, B.A., et al. CARDIoGRAMplusC4D Consortium DIAGRAM Consortium CARDIOGENICS Consortium MuTHER Consortium, Wellcome Trust Case Control Consortium. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat. Genet. 45 (2013), 25–33.
26. Duewell, P., Kono, H., Rayner, K.J., Sirois, C.M., Vladimer, G., Bauernfeind, F.G., Abela, G.S., Franchi, L., Nuñez, G., Schnurr, M., et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464 (2010), 1357–1361.
27. Dullaart, R.P.F., PCSK9 inhibition to reduce cardiovascular events. N. Engl. J. Med. 376 (2017), 1790–1791.
28. Dutta, P., Courties, G., Wei, Y., Leuschner, F., Gorbatov, R., Robbins, C.S., Iwamoto, Y., Thompson, B., Carlson, A.L., Heidt, T., et al. Myocardial infarction accelerates atherosclerosis. Nature 487 (2012), 325–329.
29. Eid, R.E., Rao, D.A., Zhou, J., Lo, S.F., Ranjbaran, H., Gallo, A., Sokol, S.I., Pfau, S., Pober, J.S., Tellides, G., Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells. Circulation 119 (2009), 1424–1432.
30. Erbilgin, A., Civelek, M., Romanoski, C.E., Pan, C., Hagopian, R., Berliner, J.A., Lusis, A.J., Identification of CAD candidate genes in GWAS loci and their expression in vascular cells. J. Lipid Res. 54 (2013), 1894–1905.
31. Fogelstrand, P., Borén, J., Retention of atherogenic lipoproteins in the artery wall and its role in atherogenesis. Nutr. Metab. Cardiovasc. Dis. 22 (2012), 1–7.
32. Franck, G., Mawson, T., Sausen, G., Salinas, M., Masson, G.S., Cole, A., Beltrami-Moreira, M., Chatzizisis, Y., Quillard, T., Tesmenitsky, Y., et al. Flow Perturbation Mediates Neutrophil Recruitment and Potentiates Endothelial Injury via TLR2 in Mice: Implications for Superficial Erosion. Circ. Res. 121 (2017), 31–42.
33. Fredman, G., Kamaly, N., Spolitu, S., Milton, J., Ghorpade, D., Chiasson, R., Kuriakose, G., Perretti, M., Farokhzad, O., Tabas, I., Targeted nanoparticles containing the proresolving peptide Ac2-26 protect against advanced atherosclerosis in hypercholesterolemic mice. Sci. Transl. Med., 7, 2015, 275ra20.
34. Fredman, G., Hellmann, J., Proto, J.D., Kuriakose, G., Colas, R.A., Dorweiler, B., Connolly, E.S., Solomon, R., Jones, D.M., Heyer, E.J., et al. An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques. Nat. Commun., 7, 2016, 12859.
35. Fuster, J.J., MacLauchlan, S., Zuriaga, M.A., Polackal, M.N., Ostriker, A.C., Chakraborty, R., Wu, C.L., Sano, S., Muralidharan, S., Rius, C., et al. Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice. Science 355 (2017), 842–847.
36. Gagliani, N., Amezcua Vesely, M.C., Iseppon, A., Brockmann, L., Xu, H., Palm, N.W., de Zoete, M.R., Licona-Limón, P., Paiva, R.S., Ching, T., et al. Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation. Nature 523 (2015), 221–225.
37. Garbin, U., Baggio, E., Stranieri, C., Pasini, A., Manfro, S., Mozzini, C., Vallerio, P., Lipari, G., Merigo, F., Guidi, G., et al. Expansion of necrotic core and shedding of Mertk receptor in human carotid plaques: a role for oxidized polyunsaturated fatty acids?. Cardiovasc. Res. 97 (2013), 125–133.
38. Gautier, E.L., Westerterp, M., Bhagwat, N., Cremers, S., Shih, A., Abdel-Wahab, O., Lütjohann, D., Randolph, G.J., Levine, R.L., Tall, A.R., Yvan-Charvet, L., HDL and Glut1 inhibition reverse a hypermetabolic state in mouse models of myeloproliferative disorders. J. Exp. Med. 210 (2013), 339–353.
39. Geng, Y.-J., Libby, P., Evidence for apoptosis in advanced human atheroma. Colocalization with interleukin-1 β-converting enzyme. Am. J. Pathol. 147 (1995), 251–266.
40. Gimbrone, M.A. Jr., García-Cardeña, G., Vascular endothelium, hemodynamics, and the pathobiology of atherosclerosis. Cardiovasc. Pathol. 22 (2013), 9–15.
41. Gisterå A., Hermansson, A., Strodthoff, D., Klement, M.L., Hedin, U., Fredrikson, G.N., Nilsson, J., Hansson, G.K., Ketelhuth, D.F., Vaccination against T-cell epitopes of native ApoB100 reduces vascular inflammation and disease in a humanized mouse model of atherosclerosis. J. Intern. Med. 281 (2017), 383–397.
42. Glass, C.K., Witztum, J.L., Atherosclerosis. the road ahead. Cell 104 (2001), 503–516.
43. Go, A.S., Mozaffarian, D., Roger, V.L., Benjamin, E.J., Berry, J.D., Borden, W.B., Bravata, D.M., Dai, S., Ford, E.S., Fox, C.S., et al., American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Executive summary: heart disease and stroke statistics–2013 update: a report from the American Heart Association. Circulation 127 (2013), 143–152.
44. Gosselin, D., Link, V.M., Romanoski, C.E., Fonseca, G.J., Eichenfield, D.Z., Spann, N.J., Stender, J.D., Chun, H.B., Garner, H., Geissmann, F., Glass, C.K., Environment drives selection and function of enhancers controlling tissue-specific macrophage identities. Cell 159 (2014), 1327–1340.
45. Han, S., Liang, C.P., DeVries-Seimon, T., Ranalletta, M., Welch, C.L., Collins-Fletcher, K., Accili, D., Tabas, I., Tall, A.R., Macrophage insulin receptor deficiency increases ER stress-induced apoptosis and necrotic core formation in advanced atherosclerotic lesions. Cell Metab. 3 (2006), 257–266.
46. Hanna, R.N., Carlin, L.M., Hubbeling, H.G., Nackiewicz, D., Green, A.M., Punt, J.A., Geissmann, F., Hedrick, C.C., The transcription factor NR4A1 (Nur77) controls bone marrow differentiation and the survival of Ly6C- monocytes. Nat. Immunol. 12 (2011), 778–785.
47. Hasturk, H., Abdallah, R., Kantarci, A., Nguyen, D., Giordano, N., Hamilton, J., Van Dyke, T.E., Resolvin E1 (RvE1) attenuates atherosclerotic plaque formation in diet and inflammation-induced atherogenesis. Arterioscler. Thromb. Vasc. Biol. 35 (2015), 1123–1133.
48. Heidt, T., Sager, H.B., Courties, G., Dutta, P., Iwamoto, Y., Zaltsman, A., von Zur Muhlen, C., Bode, C., Fricchione, G.L., Denninger, J., et al. Chronic variable stress activates hematopoietic stem cells. Nat. Med. 20 (2014), 754–758.
49. Henson, P.M., Bratton, D.L., Fadok, V.A., Apoptotic cell removal. Curr. Biol. 11 (2001), R795–R805.
50. Hilgendorf, I., Swirski, F.K., Making a difference: monocyte heterogeneity in cardiovascular disease. Curr. Atheroscler. Rep. 14 (2012), 450–459.
51. Hilgendorf, I., Gerhardt, L.M., Tan, T.C., Winter, C., Holderried, T.A., Chousterman, B.G., Iwamoto, Y., Liao, R., Zirlik, A., Scherer-Crosbie, M., et al. Ly-6Chigh monocytes depend on Nr4a1 to balance both inflammatory and reparative phases in the infarcted myocardium. Circ. Res. 114 (2014), 1611–1622.
52. Hoeksema, M.A., Gijbels, M.J., Van den Bossche, J., van der Velden, S., Sijm, A., Neele, A.E., Seijkens, T., Stöger, J.L., Meiler, S., Boshuizen, M.C., et al. Targeting macrophage Histone deacetylase 3 stabilizes atherosclerotic lesions. EMBO Mol. Med. 6 (2014), 1124–1132.
53. Hoseini, Z., Sepahvand, F., Rashidi, B., Sahebkar, A., Masoudifar, A., Mirzaei, H., NLRP3 inflammasome: Its regulation and involvement in atherosclerosis. J. Cell. Physiol., 2017, 10.1002/jcp.25930 Published online March 27, 2017.
54. Huang, W.C., Sala-Newby, G.B., Susana, A., Johnson, J.L., Newby, A.C., Classical macrophage activation up-regulates several matrix metalloproteinases through mitogen activated protein kinases and nuclear factor-κB. PLoS ONE, 7, 2012, e42507.
55. Jahagirdar, R., Zhang, H., Azhar, S., Tobin, J., Attwell, S., Yu, R., Wu, J., McLure, K.G., Hansen, H.C., Wagner, G.S., et al. A novel BET bromodomain inhibitor, RVX-208, shows reduction of atherosclerosis in hyperlipidemic ApoE deficient mice. Atherosclerosis 236 (2014), 91–100.
56. Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P.V., Mar, B.G., Lindsley, R.C., Mermel, C.H., Burtt, N., Chavez, A., et al. Age-related clonal hematopoiesis associated with adverse outcomes. N. Engl. J. Med. 371 (2014), 2488–2498.
57. Jaiswal, S., Natarajan, P., Silver, A.J., Gibson, C.J., Bick, A.G., Shvartz, E., McConkey, M., Gupta, N., Gabriel, S., Ardissino, D., et al. Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease. N. Engl. J. Med. 377 (2017), 111–121.
58. Jakubzick, C.V., Randolph, G.J., Henson, P.M., Monocyte differentiation and antigen-presenting functions. Nat. Rev. Immunol. 17 (2017), 349–362.
59. Jongstra-Bilen, J., Haidari, M., Zhu, S.N., Chen, M., Guha, D., Cybulsky, M.I., Low-grade chronic inflammation in regions of the normal mouse arterial intima predisposed to atherosclerosis. J. Exp. Med. 203 (2006), 2073–2083.
60. Kanter, J.E., Kramer, F., Barnhart, S., Averill, M.M., Vivekanandan-Giri, A., Vickery, T., Li, L.O., Becker, L., Yuan, W., Chait, A., et al. Diabetes promotes an inflammatory macrophage phenotype and atherosclerosis through acyl-CoA synthetase 1. Proc. Natl. Acad. Sci. USA 109 (2012), E715–E724.
61. Kimura, T., Tse, K., McArdle, S., Gerhardt, T., Miller, J., Mikulski, Z., Sidney, J., Sette, A., Wolf, D., Ley, K., Atheroprotective vaccination with MHC-II-restricted ApoB peptides induces peritoneal IL-10-producing CD4 T cells. Am. J. Physiol. Heart Circ. Physiol. 312 (2017), H781–H790.
62. Kojima, Y., Volkmer, J.P., McKenna, K., Civelek, M., Lusis, A.J., Miller, C.L., Direnzo, D., Nanda, V., Ye, J., Connolly, A.J., et al. CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis. Nature 536 (2016), 86–90.
63. Kuo, C.L., Murphy, A.J., Sayers, S., Li, R., Yvan-Charvet, L., Davis, J.Z., Krishnamurthy, J., Liu, Y., Puig, O., Sharpless, N.E., et al. Cdkn2a is an atherosclerosis modifier locus that regulates monocyte/macrophage proliferation. Arterioscler. Thromb. Vasc. Biol. 31 (2011), 2483–2492.
64. Lakatta, E.G., Levy, D., Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a “set up” for vascular disease. Circulation 107 (2003), 139–146.
65. Lavin, Y., Winter, D., Blecher-Gonen, R., David, E., Keren-Shaul, H., Merad, M., Jung, S., Amit, I., Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment. Cell 159 (2014), 1312–1326.
66. Levine, A.G., Medoza, A., Hemmers, S., Moltedo, B., Niec, R.E., Schizas, M., Hoyos, B.E., Putintseva, E.V., Chaudhry, A., Dikiy, S., et al. Stability and function of regulatory T cells expressing the transcription factor T-bet. Nature 546 (2017), 421–425.
67. Li, J., McArdle, S., Gholami, A., Kimura, T., Wolf, D., Gerhardt, T., Miller, J., Weber, C., Ley, K., CCR5+T-bet+FoxP3+ effector CD4 T Cells drive atherosclerosis. Circ. Res. 118 (2016), 1540–1552.
68. Libby, P., Mechanisms of acute coronary syndromes and their implications for therapy. N. Engl. J. Med. 368 (2013), 2004–2013.
69. Libby, P., Superficial erosion and the precision management of acute coronary syndromes: not one-size-fits-all. Eur. Heart J. 38 (2017), 801–803.
70. Lichtman, A.H., T cell costimulatory and coinhibitory pathways in vascular inflammatory diseases. Front. Physiol., 3, 2012, 18.
71. Linton, M.F., Babaev, V.R., Huang, J., Linton, E.F., Tao, H., Yancey, P.G., Macrophage apoptosis and efferocytosis in the pathogenesis of atherosclerosis. Circ. J. 80 (2016), 2259–2268.
72. Lusis, A.J., Atherosclerosis. Nature 407 (2000), 233–241.
73. MacIver, N.J., Michalek, R.D., Rathmell, J.C., Metabolic regulation of T lymphocytes. Annu. Rev. Immunol. 31 (2013), 259–283.
74. Maganto-García, E., Tarrio, M.L., Grabie, N., Bu, D.X., Lichtman, A.H., Dynamic changes in regulatory T cells are linked to levels of diet-induced hypercholesterolemia. Circulation 124 (2011), 185–195.
75. Mailer, R.K.W., Gisterå A., Polyzos, K.A., Ketelhuth, D.F.J., Hansson, G.K., Hypercholesterolemia induces differentiation of regulatory T cells in the liver. Circ. Res. 120 (2017), 1740–1753.
76. Marsch, E., Sluimer, J.C., Daemen, M.J., Hypoxia in atherosclerosis and inflammation. Curr. Opin. Lipidol. 24 (2013), 393–400.
77. Marsch, E., Theelen, T.L., Demandt, J.A., Jeurissen, M., van Gink, M., Verjans, R., Janssen, A., Cleutjens, J.P., Meex, S.J., Donners, M.M., et al. Reversal of hypoxia in murine atherosclerosis prevents necrotic core expansion by enhancing efferocytosis. Arterioscler. Thromb. Vasc. Biol. 34 (2014), 2545–2553.
78. McMullin, M.F., Wu, C., Percy, M.J., Tong, W., A nonsynonymous LNK polymorphism associated with idiopathic erythrocytosis. Am. J. Hematol. 86 (2011), 962–964.
79. Merched, A.J., Ko, K., Gotlinger, K.H., Serhan, C.N., Chan, L., Atherosclerosis: evidence for impairment of resolution of vascular inflammation governed by specific lipid mediators. FASEB J. 22 (2008), 3595–3606.
80. Meyer Zu Horste, G., Wu, C., Wang, C., Cong, L., Pawlak, M., Lee, Y., Elyaman, W., Xiao, S., Regev, A., Kuchroo, V.K., RBPJ controls development of pathogenic Th17 cells by regulating Il-23 receptor expression. Cell Rep. 16 (2016), 392–404.
81. Minamino, T., Komuro, I., Vascular cell senescence: contribution to atherosclerosis. Circ. Res. 100 (2007), 15–26.
82. Murphy, A.J., Tall, A.R., Disordered haematopoiesis and athero-thrombosis. Eur. Heart J. 37 (2016), 1113–1121.
83. Nagareddy, P.R., Murphy, A.J., Stirzaker, R.A., Hu, Y., Yu, S., Miller, R.G., Ramkhelawon, B., Distel, E., Westerterp, M., Huang, L.S., et al. Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis. Cell Metab. 17 (2013), 695–708.
84. Nathan, C., Ding, A., Nonresolving inflammation. Cell 140 (2010), 871–882.
85. Netea, M.G., Joosten, L.A., Latz, E., Mills, K.H., Natoli, G., Stunnenberg, H.G., O'Neill, L.A., Xavier, R.J., Trained immunity: A program of innate immune memory in health and disease. Science, 352, 2016, aaf1098.
86. Nus, M., Martínez-Poveda, B., MacGrogan, D., Chevre, R., D'Amato, G., Sbroggio, M., Rodríguez, C., Martínez-González, J., Andrés, V., Hidalgo, A., de la Pompa, J.L., Endothelial Jag1-RBPJ signalling promotes inflammatory leucocyte recruitment and atherosclerosis. Cardiovasc. Res., 23, 2016, 610.
87. Nus, M., Sage, A.P., Lu, Y., Masters, L., Lam, B.Y.H., Newland, S., Weller, S., Tsiantoulas, D., Raffort, J., Marcus, D., et al. Marginal zone B cells control the response of follicular helper T cells to a high-cholesterol diet. Nat. Med. 23 (2017), 601–610.
88. Olivares, R., Ducimetière, P., Claude, J.R., Monocyte count: a risk factor for coronary heart disease?. Am. J. Epidemiol. 137 (1993), 49–53.
89. Otsuka, F., Kramer, M.C., Woudstra, P., Yahagi, K., Ladich, E., Finn, A.V., de Winter, R.J., Kolodgie, F.D., Wight, T.N., Davis, H.R., et al. Natural progression of atherosclerosis from pathologic intimal thickening to late fibroatheroma in human coronary arteries: A pathology study. Atherosclerosis 241 (2015), 772–782.
90. Ouimet, M., Ediriweera, H.N., Gundra, U.M., Sheedy, F.J., Ramkhelawon, B., Hutchison, S.B., Rinehold, K., van Solingen, C., Fullerton, M.D., Cecchini, K., et al. MicroRNA-33-dependent regulation of macrophage metabolism directs immune cell polarization in atherosclerosis. J. Clin. Invest. 125 (2015), 4334–4348.
91. Packard, R.R., Maganto-García, E., Gotsman, I., Tabas, I., Libby, P., Lichtman, A.H., CD11c(+) dendritic cells maintain antigen processing, presentation capabilities, and CD4(+) T-cell priming efficacy under hypercholesterolemic conditions associated with atherosclerosis. Circ. Res. 103 (2008), 965–973.
92. Paneni, F., Diaz Cañestro, C., Libby, P., Lüscher, T.F., Camici, G.G., The aging cardiovascular system: understanding it at the cellular and clinical levels. J. Am. Coll. Cardiol. 69 (2017), 1952–1967.
93. Paulson, K.E., Zhu, S.N., Chen, M., Nurmohamed, S., Jongstra-Bilen, J., Cybulsky, M.I., Resident intimal dendritic cells accumulate lipid and contribute to the initiation of atherosclerosis. Circ. Res. 106 (2010), 383–390.
94. Peled, M., Fisher, E.A., Dynamic aspects of macrophage polarization during atherosclerosis progression and regression. Front. Immunol., 5, 2014, 579.
95. Perretti, M., D'Acquisto, F., Annexin A1 and glucocorticoids as effectors of the resolution of inflammation. Nat. Rev. Immunol. 9 (2009), 62–70.
96. Petri, M.H., Laguna-Fernandez, A., Arnardottir, H., Wheelock, C.E., Perretti, M., Hansson, G.K., Bäck, M., Aspirin-triggered lipoxin A4 inhibits atherosclerosis progression in apolipoprotein E(-/-) mice. Br. J. Pharmacol., 2017, 10.1111/bph.13707 Published online January 10, 2017.
97. Phan, A.T., Goldrath, A.W., Glass, C.K., Metabolic and epigenetic coordination of T cell and macrophage immunity. Immunity 46 (2017), 714–729.
98. Rahman, K., Vengrenyuk, Y., Ramsey, S.A., Vila, N.R., Girgis, N.M., Liu, J., Gusarova, V., Gromada, J., Weinstock, A., Moore, K.J., et al. Inflammatory Ly6Chi monocytes and their conversion to M2 macrophages drive atherosclerosis regression. J. Clin. Invest. 127 (2017), 2904–2915.
99. Razani, B., Chakravarthy, M.V., Semenkovich, C.F., Insulin resistance and atherosclerosis. Endocrinol. Metab. Clin. North Am. 37 (2008), 603–621 viii.
100. Ridker, P.M., Howard, C.P., Walter, V., Everett, B., Libby, P., Hensen, J., Thuren, T., CANTOS Pilot Investigative Group. Effects of interleukin-1β inhibition with canakinumab on hemoglobin A1c, lipids, C-reactive protein, interleukin-6, and fibrinogen: a phase IIb randomized, placebo-controlled trial. Circulation 126 (2012), 2739–2748.
101. Ridker, P.M., Everett, B.M., Thuren, T., MacFadyen, J.G., Chang, W.H., Ballantyne, C., Fonseca, F., Nicolau, J., Koenig, W., Anker, S.D., et al., CANTOS Trial Group. Antiinflammatory therapy with canakinumab for atherosclerotic disease. N. Engl. J. Med. 377 (2017), 1119–1131.
102. Robbins, C.S., Chudnovskiy, A., Rauch, P.J., Figueiredo, J.L., Iwamoto, Y., Gorbatov, R., Etzrodt, M., Weber, G.F., Ueno, T., van Rooijen, N., et al. Extramedullary hematopoiesis generates Ly-6C(high) monocytes that infiltrate atherosclerotic lesions. Circulation 125 (2012), 364–374.
103. Robbins, C.S., Hilgendorf, I., Weber, G.F., Theurl, I., Iwamoto, Y., Figueiredo, J.L., Gorbatov, R., Sukhova, G.K., Gerhardt, L.M., Smyth, D., et al. Local proliferation dominates lesional macrophage accumulation in atherosclerosis. Nat. Med. 19 (2013), 1166–1172.
104. Sakai, M., Miyazaki, A., Hakamata, H., Kodama, T., Suzuki, H., Kobori, S., Shichiri, M., Horiuchi, S., The scavenger receptor serves as a route for internalization of lysophosphatidylcholine in oxidized low density lipoprotein-induced macrophage proliferation. J. Biol. Chem. 271 (1996), 27346–27352.
105. Sakai, M., Kobori, S., Miyazaki, A., Horiuchi, S., Macrophage proliferation in atherosclerosis. Curr. Opin. Lipidol. 11 (2000), 503–509.
106. Sawant, D.V., Vignali, D.A., Once a Treg, always a Treg?. Immunol. Rev. 259 (2014), 173–191.
107. Sayin, V.I., Khan, O.M., Pehlivanoglu, L.E., Staffas, A., Ibrahim, M.X., Asplund, A., Agren, P., Nilton, A., Bergström, G., Bergo, M.O., et al. Loss of one copy of Zfp148 reduces lesional macrophage proliferation and atherosclerosis in mice by activating p53. Circ. Res. 115 (2014), 781–789.
108. Schierwagen, R., Uschner, F.E., Magdaleno, F., Klein, S., Trebicka, J., Rationale for the use of statins in liver disease. Am. J. Physiol. Gastrointest. Liver Physiol. 312 (2017), G407–G412.
109. Schrijvers, D.M., De Meyer, G.R., Kockx, M.M., Herman, A.G., Martinet, W., Phagocytosis of apoptotic cells by macrophages is impaired in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 25 (2005), 1256–1261.
110. Schrijvers, D.M., De Meyer, G.R., Herman, A.G., Martinet, W., Phagocytosis in atherosclerosis: Molecular mechanisms and implications for plaque progression and stability. Cardiovasc. Res. 73 (2007), 470–480.
111. Seijkens, T., Hoeksema, M.A., Beckers, L., Smeets, E., Meiler, S., Levels, J., Tjwa, M., de Winther, M.P., Lutgens, E., Hypercholesterolemia-induced priming of hematopoietic stem and progenitor cells aggravates atherosclerosis. FASEB J. 28 (2014), 2202–2213.
112. Senokuchi, T., Matsumura, T., Sakai, M., Yano, M., Taguchi, T., Matsuo, T., Sonoda, K., Kukidome, D., Imoto, K., Nishikawa, T., et al. Statins suppress oxidized low density lipoprotein-induced macrophage proliferation by inactivation of the small G protein-p38 MAPK pathway. J. Biol. Chem. 280 (2005), 6627–6633.
113. Serhan, C.N., Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not?. Am. J. Pathol. 177 (2010), 1576–1591.
114. Serhan, C.N., Brain, S.D., Buckley, C.D., Gilroy, D.W., Haslett, C., O'Neill, L.A., Perretti, M., Rossi, A.G., Wallace, J.L., Resolution of inflammation: state of the art, definitions and terms. FASEB J. 21 (2007), 325–332.
115. Sheedy, F.J., Grebe, A., Rayner, K.J., Kalantari, P., Ramkhelawon, B., Carpenter, S.B., Becker, C.E., Ediriweera, H.N., Mullick, A.E., Golenbock, D.T., et al. CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation. Nat. Immunol. 14 (2013), 812–820.
116. Shirai, T., Nazarewicz, R.R., Wallis, B.B., Yanes, R.E., Watanabe, R., Hilhorst, M., Tian, L., Harrison, D.G., Giacomini, J.C., Assimes, T.L., et al. The glycolytic enzyme PKM2 bridges metabolic and inflammatory dysfunction in coronary artery disease. J. Exp. Med. 213 (2016), 337–354.
117. Stöger, J.L., Gijbels, M.J., van der Velden, S., Manca, M., van der Loos, C.M., Biessen, E.A., Daemen, M.J., Lutgens, E., de Winther, M.P., Distribution of macrophage polarization markers in human atherosclerosis. Atherosclerosis 225 (2012), 461–468.
118. hi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. J. Clin. Invest. 117 (2007), 195–205.
119. Swirski, F.K., Robbins, C.S., Nahrendorf, M., Development and function of arterial and cardiac macrophages. Trends Immunol. 37 (2016), 32–40.
120. Tabas, I., Consequences and therapeutic implications of macrophage apoptosis in atherosclerosis: the importance of lesion stage and phagocytic efficiency. Arterioscler. Thromb. Vasc. Biol. 25 (2005), 2255–2264.
121. Tabas, I., Macrophage death and defective inflammation resolution in atherosclerosis. Nat. Rev. Immunol. 10 (2010), 36–46.
122. Tabas, I., Glass, C.K., Anti-inflammatory therapy in chronic disease: challenges and opportunities. Science 339 (2013), 166–172.
123. Tacke, F., Alvarez, D., Kaplan, T.J., Jakubzick, C., Spanbroek, R., Llodra, J., Garin, A., Liu, J., Mack, M., van Rooijen, N., et al. Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. J. Clin. Invest. 117 (2007), 185–194.
124. Tang, J., Lobatto, M.E., Hassing, L., van der Staay, S., van Rijs, S.M., Calcagno, C., Braza, M.S., Baxter, S., Fay, F., Sanchez-Gaytan, B.L., et al. Inhibiting macrophage proliferation suppresses atherosclerotic plaque inflammation. Sci. Adv., 1, 2015, e1400223.
125. Tao, H., Yancey, P.G., Babaev, V.R., Blakemore, J.L., Zhang, Y., Ding, L., Fazio, S., Linton, M.F., Macrophage SR-BI mediates efferocytosis via Src/PI3K/Rac1 signaling and reduces atherosclerotic lesion necrosis. J. Lipid Res. 56 (2015), 1449–1460.
126. Tawakol, A., Singh, P., Mojena, M., Pimentel-Santillana, M., Emami, H., MacNabb, M., Rudd, J.H., Narula, J., Enriquez, J.A., Través, P.G., et al. HIF-1α and PFKFB3 Mediate a Tight Relationship Between Proinflammatory Activation and Anerobic Metabolism in Atherosclerotic Macrophages. Arterioscler. Thromb. Vasc. Biol. 35 (2015), 1463–1471.
127. Trogan, E., Feig, J.E., Dogan, S., Rothblat, G.H., Angeli, V., Tacke, F., Randolph, G.J., Fisher, E.A., Gene expression changes in foam cells and the role of chemokine receptor CCR7 during atherosclerosis regression in ApoE-deficient mice. Proc. Natl. Acad. Sci. USA 103 (2006), 3781–3786.
128. Van den Bossche, J., O'Neill, L.A., Menon, D., Macrophage immunometabolism: Where are we (going)?. Trends Immunol. 38 (2017), 395–406.
129. Van Vré E.A., Ait-Oufella, H., Tedgui, A., Mallat, Z., Apoptotic cell death and efferocytosis in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 32 (2012), 887–893.
130. Viny, A.D., Levine, R.L., Genetics of myeloproliferative neoplasms. Cancer J. 20 (2014), 61–65.
131. Viola, J., Soehnlein, O., Atherosclerosis - A matter of unresolved inflammation. Semin. Immunol. 27 (2015), 184–193.
132. Viola, J.R., Lemnitzer, P., Jansen, Y., Csaba, G., Winter, C., Neideck, C., Silvestre-Roig, C., Dittmar, G., Döring, Y., Drechsler, M., et al. Resolving lipid mediators maresin 1 and resolvin D2 prevent atheroprogression in mice. Circ. Res. 119 (2016), 1030–1038.
133. Virmani, R., Burke, A.P., Kolodgie, F.D., Farb, A., Vulnerable plaque: the pathology of unstable coronary lesions. J. Interv. Cardiol. 15 (2002), 439–446.
134. Wang, Z., Klipfell, E., Bennett, B.J., Koeth, R., Levison, B.S., Dugar, B., Feldstein, A.E., Britt, E.B., Fu, X., Chung, Y.M., et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472 (2011), 57–63.
135. Wang, Y., Wang, G.Z., Rabinovitch, P.S., Tabas, I., Macrophage mitochondrial oxidative stress promotes atherosclerosis and nuclear factor-κB-mediated inflammation in macrophages. Circ. Res. 114 (2014), 421–433.
136. Wang, W., Tang, Y., Wang, Y., Tascau, L., Balcerek, J., Tong, W., Levine, R.L., Welch, C., Tall, A.R., Wang, N., LNK/SH2B3 Loss of Function Promotes Atherosclerosis and Thrombosis. Circ. Res. 119 (2016), e91–e103.
137. Wang, Y., Wang, W., Wang, N., Tall, A.R., Tabas, I., Mitochondrial oxidative stress promotes atherosclerosis and neutrophil extracellular traps in aged mice. Arterioscler. Thromb. Vasc. Biol. 37 (2017), e99–e107.
138. Watanabe, R., Shirai, T., Namkoong, H., Zhang, H., Berry, G.J., Wallis, B.B., Schaefgen, B., Harrison, D.G., Tremmel, J.A., Giacomini, J.C., et al. Pyruvate controls the checkpoint inhibitor PD-L1 and suppresses T cell immunity. J. Clin. Invest. 127 (2017), 2725–2738.
139. Wei, X., Song, H., Yin, L., Rizzo, M.G., Sidhu, R., Covey, D.F., Ory, D.S., Semenkovich, C.F., Fatty acid synthesis configures the plasma membrane for inflammation in diabetes. Nature 539 (2016), 294–298.
140. Westerterp, M., Bochem, A.E., Yvan-Charvet, L., Murphy, A.J., Wang, N., Tall, A.R., ATP-binding cassette transporters, atherosclerosis, and inflammation. Circ. Res. 114 (2014), 157–170.
141. Westerterp, M., Gautier, E.L., Ganda, A., Molusky, M.M., Wang, W., Fotakis, P., Wang, N., Randolph, G.J., D'Agati, V.D., Yvan-Charvet, L., Tall, A.R., Cholesterol accumulation in dendritic cells links the inflammasome to acquired immunity. Cell Metab. 25 (2017), 1294–1304.e6.
142. Willecke, F., Yuan, C., Oka, K., Chan, L., Hu, Y., Barnhart, S., Bornfeldt, K.E., Goldberg, I.J., Fisher, E.A., Effects of high fat feeding and diabetes on regression of atherosclerosis induced by low-density lipoprotein receptor gene therapy in LDL receptor-deficient mice. PLoS ONE, 10, 2015, e0128996.
143. Williams, K.J., Tabas, I., The response-to-retention hypothesis of early atherogenesis. Arterioscler. Thromb. Vasc. Biol. 15 (1995), 551–561.
144. Witztum, J.L., Lichtman, A.H., The influence of innate and adaptive immune responses on atherosclerosis. Annu. Rev. Pathol. 9 (2014), 73–102.
145. Wu, X.Q., Dai, Y., Yang, Y., Huang, C., Meng, X.M., Wu, B.M., Li, J., Emerging role of microRNAs in regulating macrophage activation and polarization in immune response and inflammation. Immunology 148 (2016), 237–248.
146. Xu, Y., Chaudhury, A., Zhang, M., Savoldo, B., Metelitsa, L.S., Rodgers, J., Yustein, J.T., Neilson, J.R., Dotti, G., Glycolysis determines dichotomous regulation of T cell subsets in hypoxia. J. Clin. Invest. 126 (2016), 2678–2688.
147. Yancey, P.G., Blakemore, J., Ding, L., Fan, D., Overton, C.D., Zhang, Y., Linton, M.F., Fazio, S., Macrophage LRP-1 controls plaque cellularity by regulating efferocytosis and Akt activation. Arterioscler. Thromb. Vasc. Biol. 30 (2010), 787–795.
148. Yang, W., Bai, Y., Xiong, Y., Zhang, J., Chen, S., Zheng, X., Meng, X., Li, L., Wang, J., Xu, C., et al. Potentiating the antitumour response of CD8(+) T cells by modulating cholesterol metabolism. Nature 531 (2016), 651–655.
149. Yu, F., Sharma, S., Edwards, J., Feigenbaum, L., Zhu, J., Dynamic expression of transcription factors T-bet and GATA-3 by regulatory T cells maintains immunotolerance. Nat. Immunol. 16 (2015), 197–206.
150. Yvan-Charvet, L., Pagler, T., Gautier, E.L., Avagyan, S., Siry, R.L., Han, S., Welch, C.L., Wang, N., Randolph, G.J., Snoeck, H.W., Tall, A.R., ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation. Science 328 (2010), 1689–1693.
151. Zhang, Q., Zhao, K., Shen, Q., Han, Y., Gu, Y., Li, X., Zhao, D., Liu, Y., Wang, C., Zhang, X., et al. Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6. Nature 525 (2015), 389–393.